VEPURED®, the new purified vaccine against edema disease from HIPRA
On 19th October last, HIPRA launched the new VEPURED® vaccine against edema disease. The event, which took place in Germany, was attended by over 200 specialist veterinarians from Europe and Russia.
8 November 2017
2 minute read
Under the theme of “What is behind our vaccines?”, those present were able to find out about the different phases of development of VEPURED® from the HIPRA R+D team.
VEPURED® is the only vaccine on the market indicated for administration from the second day of life and designed to prevent mortality and reduce losses in average daily weight gain associated with VT2e infection.
